Patients Stopping Weight-Loss Jabs Regain Weight Four Times Faster Than Those on Conventional Diets

New research suggests that people who discontinue popular weight-loss injections like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who end traditional diet and exercise regimens.

Published data in a major health publication points out that while obese individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"Individuals purchasing these treatments must be aware of the danger of quick rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.

That rate of regain suggests a return to original mass in about one and a half years.

Weighing Therapies

The analysis, which reviewed 37 of trials involving thousands of participants, contrasted the effects of these new drugs with other pills.

Scientists point out that people who lose weight through dieting typically have a slower creep back—approximately 100 grams monthly—after stopping.

The Reason for the Fast Regain

Nutrition scientists suggest the mechanism of the injections is key to understanding the amplified rebound.

These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.

"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this hormone supplement results in appetite is no longer kept in check, making binge eating a significant risk."

A Chronic Condition?

The NHS recommend the injections for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians say that, due to the significant potential of weight regain, the therapy might need to be ongoing.

This perspective is supported by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," akin to managing conditions like hypertension.

Patient Testimonies

People who have stopped the jabs describe a powerful resurgence of hunger.

"I experienced a trigger activating and you're instantly extremely hungry," described one woman.

This challenge is worsened if individuals have not adopted lasting dietary or behavioural changes during therapy.

Significant Interest

Figures show that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

• Adoption is more common among females than men.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

Finally, experts caution that while these medications are effective tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on integrated behavioural changes.